{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:10:40Z","timestamp":1784740240120,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.msard.2021.102975","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T01:27:34Z","timestamp":1619227654000},"page":"102975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Multiple sclerosis-like NMOSD patients suffer severe worsening of status after fingolimod initiation"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1401-3921","authenticated-orcid":false,"given":"Mickael","family":"Bonnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Berthelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Cabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 12","key":"10.1016\/j.msard.2021.102975_bib0001","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/brain\/awh624","article-title":"Role of return migration in the emergence of multiple sclerosis in the French West Indies","volume":"128","author":"Cabre","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.msard.2021.102975_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3678152","article-title":"Circulating memory t follicular helper cells in patients with neuromyelitis optica\/neuromyelitis optica spectrum disorders","author":"Fan","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.msard.2021.102975_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102425","article-title":"Epidemiology and comorbidities of adult multiple sclerosis and neuromyelitis optica in Taiwan, 2001-2015","volume":"45","author":"Fang","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2021.102975_bib0004","article-title":"Short segment myelitis as the initial and only manifestation of aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorders","volume":"13","author":"Fang","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"5","key":"10.1016\/j.msard.2021.102975_bib0005","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2021.102975_bib0006","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front. Neurol."},{"issue":"1-2","key":"10.1016\/j.msard.2021.102975_bib0007","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2009.01.008","article-title":"Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey","volume":"280","author":"Ishizu","year":"2009","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.msard.2021.102975_bib0008","doi-asserted-by":"crossref","first-page":"513","DOI":"10.5692\/clinicalneurol.53.513","article-title":"A case of neuromyelitis optica spectrum disorder developing a fulminant course with multiple white-matter lesions following fingolimod treatment","volume":"53","author":"Izaki","year":"2013","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.msard.2021.102975_bib0009","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2377-14-21","article-title":"Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension","volume":"14","author":"Kira","year":"2014","journal-title":"BMC Neurol."},{"issue":"6","key":"10.1016\/j.msard.2021.102975_bib0010","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1212\/NXI.0000000000000401","article-title":"Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate","volume":"4","author":"Mathias","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.msard.2021.102975_bib0011","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1212\/01.WNL.0000094316.90240.EB","article-title":"Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000","volume":"61","author":"Mayr","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2021.102975_bib0012","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1352458511431973","article-title":"Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder","volume":"18","author":"Min","year":"2012","journal-title":"Mult. Scler."},{"issue":"12","key":"10.1016\/j.msard.2021.102975_bib0013","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1194\/jlr.P054163","article-title":"Individual variation of human S1P(1) coding sequence leads to heterogeneity in receptor function and drug interactions","volume":"55","author":"Obinata","year":"2014","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.msard.2021.102975_bib0014","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI45403","article-title":"Engagement of S1P(1)-degradative mechanisms leads to vascular leak in mice","volume":"121","author":"Oo","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.msard.2021.102975_bib0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1352458508098372","article-title":"Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years","volume":"15","author":"Osoegawa","year":"2009","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.msard.2021.102975_bib0016","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1007\/s12035-016-0075-0","article-title":"High-resolution expression profiling of peripheral blood CD8(+) cells in patients with multiple sclerosis displays fingolimod-induced immune cell redistribution","volume":"54","author":"Roch","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.msard.2021.102975_bib0017","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/25785826.2018.1531190","article-title":"Blood-brain barrier dysfunction in immuno-mediated neurological diseases","volume":"41","author":"Shimizu","year":"2018","journal-title":"Immunol. Med."},{"key":"10.1016\/j.msard.2021.102975_bib0018","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/cen3.12032","article-title":"Longitudinally extensive spinal cord lesion after initiation, and multiple extensive brain lesions after cessation of fingolimod treatment in a patient with recurrent myelitis and anti-aquaporin 4 antibodies","volume":"4","author":"Tanaka","year":"2013","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.msard.2021.102975_bib0019","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3389\/fneur.2018.00782","article-title":"Rebound After Fingolimod and a single daclizumab injection in a patient retrospectively diagnosed with NMO spectrum disorder-MRI apparent diffusion coefficient maps in differential diagnosis of demyelinating CNS disorders","volume":"9","author":"Wagner","year":"2018","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2021.102975_bib0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.msard.2021.102975_bib0021","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1073\/pnas.1618659114","article-title":"Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1","volume":"114","author":"Yanagida","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.msard.2021.102975_bib0022","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.msard.2016.03.004","article-title":"Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder","volume":"7","author":"Yoshii","year":"2016","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482100242X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482100242X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:53:07Z","timestamp":1761900787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482100242X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":22,"alternative-id":["S221103482100242X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.102975","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple sclerosis-like NMOSD patients suffer severe worsening of status after fingolimod initiation","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.102975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102975"}}